It's been an up-and-down year for NxStage Medical (NASDAQ: NXTM) shareholders. The medical technology company's stock dropped over 35% by mid-February only to rebound strongly over the past three ...

Please provide your email address to receive an email when new articles are posted on . We were unable to process your request. Please try again later. If you continue to have this issue please ...

The pending acquisition by Fresenius put NxStage's second-quarter financial report in a much different context. Coming into Monday's second-quarter financial report, NxStage investors had no inkling ...

NxStage Medical, Inc.NXTM announced that its Nx2me Connected Health (remote patient management system) reduces home hemodialysis technique failure or conversion to in-center hemodialysis by 29%.